Bank of the West’s iShares Biotechnology ETF IBB Stock Holding History

Bank of the West’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-2,020	Closed	-$216K	–	306
2017 Q4	$216K	Buy	+2,020	New	+$216K	0.03%	278
2015 Q3	–	Sell	-1,710	Closed	-$210K	–	285
2015 Q2	$210K	Sell	1,710 -210	-11%	-$25.1K	0.03%	275
2015 Q1	$220K	Buy	+1,920	New	+$212K	0.03%	267
2014 Q3	–	Sell	-2,505	Closed	-$215K	–	262
2014 Q2	$215K	Buy	+2,505	New	+$197K	0.03%	243

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of the West's IBB Position: Q1 2018 in Review

Bank of the West sold out of iShares Biotechnology ETF (IBB) in Q1 2018, closing a stake of 2,020 shares — an estimated $216K sold.

Bank of the West first reported a position in IBB in Q2 2014 and held it in 4 quarters. The position peaked at $220K in Q1 2015. 608 funds tracked by Wall St. Rank hold IBB as of Q1 2018.

Bank of the West reported no remaining iShares Biotechnology ETF position as of Q1 2018 after selling out during the quarter.
Bank of the West sold 2,020 iShares Biotechnology ETF shares in Q1 2018, an estimated $216K.
Bank of the West first reported a position in iShares Biotechnology ETF in Q2 2014 and held it in 4 quarters.
Bank of the West's iShares Biotechnology ETF position peaked at $220K in Q1 2015.
608 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2018.

Based on Bank of the West's 13F filing for Q1 2018, filed 8 May 2018.